Objective
Design
Setting
Patient(s)
Intervention(s)
Main Outcome Measure(s)
Result(s)
Conclusion(s)
Key Words
Adashi E, Bell A, Farquhar C, Allen B, de Ziegler D, Fujimoto V et al. White paper: Access to Care Summit 2015. Available at: https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/news-and-research/press-releases-and-bulletins/pdf/atcwhitepaper.pdf. Accessed February 16, 2021.
Materials and methods
Data Collection
Statistical Analysis
Results
Demographics
Demographic | No. (%) |
---|---|
Race or ethnicity (N = 1,460) | |
Non-Hispanic White | 1,054 (72.2%) |
Non-Hispanic Black or AA | 102 (7.0%) |
Hispanic/Latinx | 79 (5.4%) |
Non-Hispanic Asian | 146 (10.0%) |
Other | 79 (5.4%) |
Relationship status (N = 1,457) | |
Single | 99 (6.8%) |
Heterosexual relationship | 1,264 (86.8%) |
Divorced or separated | 16 (1.1%) |
Same-sex relationship | 74 (5.1%) |
Other | 4 (0.3%) |
Religion (N = 1,418) | |
Catholic | 531 (38.3%) |
Protestant | 212 (15.0%) |
Other Christian | 102 (7.2%) |
Judaism | 122 (8.6%) |
Hinduism | 48 (3.4%) |
Secular/agnostic/nonreligious | 360 (25.4%) |
Other | 43 (3.0%) |
Education (N = 1,458) | |
Less than a bachelor’s degree | 76 (5.2%) |
4-year college (bachelor’s degree) | 512 (35.2%) |
Master’s degree | 591 (40.5%) |
Professional degree | 279 (19.1%) |
Annual household income (N=1,440) | |
<$50,000 | 41 (2.9%) |
$50,001–$100,000 | 230 (16.0%) |
$100,001–$200,000 | 589 (40.9%) |
$200,001–$400,000 | 425 (29.5%) |
>$400,000 | 155 (10.8%) |
Insurance coverage for fertility treatment (N = 1,436) | |
No coverage | 264 (18.4%) |
<50% coverage | 83 (5.8%) |
50%–74% coverage | 300 (20.9%) |
75%–100% coverage | 789 (54.9%) |
Characteristics of Respondents Seen with Infertility
Characteristic | Overall | No. of complete cases | White | Black | Hispanic | Asian | Multiple/other | Test statistic/unadjusted P value for omnibus test/ adjusted P value | No coverage | <50% coverage | 50%–74% coverage | 75%–100% coverage | Test statistic/unadjusted P value for omnibus test/adjusted P value | <$100,000 | $100,001– $200,000 | $200,001– $400,000 | >$400,000 | Test statistic/unadjusted P value for omnibus test/adjusted P value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age [mean (95% CI)] | 36.2 (35.9–36.4) | 1442 | 35.9 (35.7–36.2) | 38.0 (37.0–39.0) | 35.7 (34.6–36.8) | 36.4 (35.7–37.1) | 36.8 (35.8–37.8) | ANOVA F = 5.7; P<.001; P<.001 | 36.5 (36.0–37.0) | 36.6 (35.7–37.6) | 35.8 (35.3–36.3) | 36.2 (35.9–36.5) | ANOVA F = 1.4; P=.25P=.03 | 35.4 (34.8-35.9) | 36.2 (35.9-36.6) | 36.2 (35.8-36.6) | 37.1 (36.4-37.8) | ANOVA F Test=12.3; =0.001 P=.0008 |
Duration attempting to conceive before seeking treatment, months [(median (IQR)] | 23.0 (47) | 1459 | 23 (40) | 28 (49) | 38 (45) | 28 (45) | 25 (37) | Kruskal-Wallis X2 = .38; df(4); P=.83P=.71 | 13 (47) | 23 (51) | 23 (40) | 28 (40) | Kruskal-Wallis X2 = 12.0;df(3); P=.007P=.11 | 23 (47) | 25 (40) | 28 (40) | 23 (40) | Kruskal-Wallis X2 = 9.8; df(3); P=.02P=.03 |
Distance traveled to clinic, miles [(median (IQR)] | 5.8 (12) | 1450 | 5 (12) | 10 (15) | 10 (10) | 5 (13) | 6 (6) | Kruskal-Wallis X2 = 12.7; (df)4; P=.010 P=.23 | 8.8 (12) | 6.5 (13) | 5.3 (12) | 5 (9) | Kruskal-Wallis X2=11.2; df(3); P=.01P=.06 | 10 (15) | 7.3 (11) | 5 (7.5) | 4 (5) | Kruskal-Wallis X2 = 96.2; (df(3); <0.001 P<.001 |
Nulliparous [N(%)] | 782 (55.7%) | 1405 | 531 (52.5%) | 74 (74.0%) | 43 (58.1%) | 84 (59.2%) | 50 (64.1%) | X2 = 20.8; (df)4; P<.001; P=.01 | 165 (64.7%) | 50 (64.1%) | 155 (54.8%) | 397 (51.8%) | X2=15.5; df(3); P=.001P<.001 | 171 (66.3%) | 341 (60.7%) | 201 (48.2%) | 58 (38.9%) | X2 = 43.8; df(3); P<.001P<.001 |
History of miscarriage [N(%)] | 590 (40.9%) | 1442 | 439 (42.2%) | 30 (30.0%) | 32 (41.6%) | 58 (39.7%) | 31 (39.7%) | X2 = 5.8; (df)4; P=.22 P=.14 | 96 (36.5%) | 33 (40.7%) | 131 (44.7%) | 322 (41.2%) | X2=3.9; df(3); P=.28 P=.12 | 96 (36.0%) | 229 (39.5%) | 176 (41.8%) | 80 (52.0%) | X2= 11.1; df(3); P=.01 P=.48 |
Completed fertility treatment (vs. currently seeking/undergoing Tx)[N(%)] | 866 (59.3%) | 1460 | 646 (61.3%) | 54 (52.9%) | 41 (51.9%) | 80 (54.8%) | 45 (57.0%) | X2 = 6.6; (df)4; P=.16P=.84 | 155 (58.7%) | 45 (54.2%) | 184 (61.3%) | 474 (60.1%) | X2=1.5; df(3); P=.68P=.57 | 147 (54.2%) | 344 (58.4%) | 264 (62.1%) | 101 (65.2%) | X2 = 6.7; df(3); P=.08P=.95 |
Referral type | N(%) | |||||||||||||||||
Friend/relative/coworker N(%) | 301 (20.7%) | 1455 | 224 (21.3%) | 18 (17.8%) | 17 (21.8%) | 32 (22.1%) | 10 (12.7%) | X2 = 4.1; df(4); P=.40 P=.21 | 62 (23.5%) | 14 (16.9%) | 65 (21.8%) | 154 (19.6%) | X2=2.8; df(3); P=.42 P=.41 | 40 (14.8%) | 123 (20.9%) | 98 (23.2%) | 36 (23.4%) | X2 = 8.2; df(3); P=.04 P=.07 |
Obstetrician/gynecologist Physician N(%) | 707 (48.6%) | 1455 | 533 (50.7%) | 46 (45.5%) | 29 (37.2%) | 61 (42.1%) | 38 (48.1%) | X2 = 8.7; df(4); P=.07 P=.18 | 109 (41.3%) | 42 (50.6%) | 144 (48.3%) | 402 (51.2%) | X2=7.8; df(3); P=.05 P=.08 | 123 (45.4%) | 284 (48.3%) | 225 (53.3%) | 69 (44.8%) | X2 = 5.8; df(3); P=.12 P=.34 |
Primary care physician N(%) | 72 (5.0%) | 1455 | 53 (5.0%) | 7 (6.9%) | 3 (3.9%) | 3 (2.1%) | 6 (7.6%) | X2 = 4.8; df(4); P=.31 P=.66 | 17 (6.4%) | 6 (7.2%) | 16 (5.4%) | 33 (4.2%) | X2=3.1; df(3); P=.37 P=.45 | 21 (7.8%) | 25 (4.3%) | 17 (4.0%) | 8 (5.2%) | X2 = 5.9; df(3); P=.12 P=.77 |
Insurance company N(%) | 53 (3.6%) | 1455 | 37 (3.5%) | 3 (3.0%) | 2 (2.6%) | 9 (6.2%) | 2 (2.5%) | X2 = 3.4; df(4); P=.49 P=.14 | 10 (3.8%) | 3(3.6%) | 8 (2.7%) | 32 (4.1%) | X2 =1.2; df(3); P=.76 P=.36 | 15 (5.5%) | 25 (4.3%) | 9 (2.1%) | 4 (2.6%) | X2 = 6.5; df(3); P=.09 P=.08 |
Internet N(%) | 168 (11.6%) | 1455 | 100 (9.5%) | 12 (11.9%) | 14 (18.0%) | 30 (20.7%) | 12 (15.2%) | X2 = 20.3; df(4); P<.001 P=.16 | 35 (13.3%) | 9 (10.8%) | 29 (9.7%) | 91 (11.6%) | X2 = 1.8; df(3); P=.62 P=.42 | 36 (13.3%) | 64 (10.9%) | 49 (11.6%) | 17 (11.0%) | X2 = 1.1; df(3); P=.78 P=.95 |
Physician diagnosed cause of infertility | N(%) | |||||||||||||||||
Ovulation problem N(%) | 307 (21.0%) | 1460 | 225 (21.4%) | 16 (15.7%) | 18 (22.8%) | 30 (20.6%) | 18 (22.8%) | X2 = 2.1; df(4); P=.71 P=.95 | 45 (17.1%) | 16 (19.3%) | 68 (22.7%) | 168 (21.3%) | X2 = 3.1; df(3); P=.37 P=.36 | 61 (22.5%) | 120 (20.4%) | 90 (21.2%) | 33 (21.3%) | X2 = .51; df(3); P=.92P=.85 |
Male factor N(%) | 233 (16.0%) | 1460 | 174 (16.5%) | 13 (12.8%) | 13 (16.5%) | 18 (12.3%) | 15 (19.0%) | X2 = 3.0; df(4); P=.56 P=.54 | 49 (18.6%) | 13 (15.7%) | 43 (14.3%) | 126 (16.0%) | X2 = 1.9; df(3); P=.59 P=.36 | 40 (14.8%) | 87 (14.8%) | 79 (18.6%) | 23 (14.8%) | X2 = 3.3; df(3); P=.35 P=.78 |
Advanced age/decreased ovarian reserve N(%) | 382 (26.2%) | 1460 | 265 (25.1%) | 28 (27.5%) | 17 (21.5%) | 44 (30.1%) | 28 (35.4%) | X2 = 6.3; df(4); P=.18 P=.008 | 61 (23.1%) | 31 (37.4%) | 81 (27.0%) | 206 (26.1%) | X2 = 6.7; df(3); P=.08 P=.11 | 64 (23.6%) | 156 (26.5%) | 108 (25.4%) | 48 (31.0%) | X2 = 2.9; df(3); P=.40 P=.99 |
Uterine Factor N(%) | 100 (6.9%) | 1460 | 70 (6.6%) | 15 (14.7%) | 1 (1.3%) | 12 (8.2%) | 2 (2.5%) | X2 = 16.5; df(4); P=.002; P<.001 | 15 (5.7%) | 8 (9.6%) | 20 (6.7%) | 56 (7.1%) | X2 = 1.7; df(3); P=.65 P=.35 | 22 (8.1%) | 34 (5.8%) | 33 (7.8%) | 7 (4.5%) | X2 = 3.7; df(3); P=.30 P=.57 |
Blocked fallopian tubes N(%) | 90 (6.2%) | 1460 | 55 (5.2%) | 20 (19.6%) | 7 (8.9%) | 5 (3.4%) | 3 (3.8%) | X2 = 37.2; df(4); P<.001 P=.046 | 18 (6.8%) | 4 (4.8%) | 19 (6.3%) | 48 (6.1%) | X2 = 0.47; df(3); P=.93 P=.80 | 27 (10.0%) | 34 (5.8%) | 20 (4.7%) | 6 (3.9%) | X2 = 10.0; df(3); P=.02 P=.70 |
Endometriosis N(%) | 89 (6.1%) | 1460 | 61 (5.8%) | 7 (6.9%) | 6 (7.6%) | 11 (7.5%) | 4 (5.1%) | X2=1.3; df(4); P=.87 P=.70 | 15 (5.7%) | 4 (4.8%) | 24 (8.0%) | 44 (5.6%) | X2 = 2.6; df(3); P=.46 P=.43 | 20 (7.4%) | 41 (7.0%) | 23 (5.4%) | 4 (2.6%) | X2 = 5.2; df(3); P=.16 P=.26 |
Fertility preservation (cancer) N(%) | 34 2.3%) | 1460 | 25 (2.4%) | 4 (3.9%) | 4 (5.1%) | 1 (.7%) | 0 (0%) | X2 = 7.4; df(4); P=.12 P= .40 | 13 (4.9%) | 2 (2.4%) | 9 (.3.0%) | 10 (1.3%) | X2 = 12.1; df(3); P=.007 P=.04 | 11 (4.1%) | 15 (2.6%) | 4 (.9%) | 3 (1.9%) | X2 = 7.5; df(3); P=.06 P=.07 |
Fertility preservation (elective) N(%) | 18 (1.2%) | 1460 | 17 (1.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (1.3%) | X2 = 5.3; df(4); P=.26 P=.85 | 8 (3.0%) | 1 (1.2%) | 6 (2.0%) | 3 (.4%) | X2 = 12.0; df(3); P=.005 P=.01 | 7 (2.6%) | 9 (1.5%) | 2 (0.5%) | 0 (0%) | X2 = 8.3; df(3); P=.04 P=.05 |
Genetic factor N(%) | 36 (2.5%) | 1460 | 31 (2.9%) | 1 (1.0%) | 1 (1.3%) | 2 (1.4%) | 1 (1.3%) | X2 = 3.6; df(4); P=.46 P= .92 | 6 (2.3%) | 3 (3.6%) | 11 (3.7%) | 15 (1.9%) | X2 = 3.4; df(3); P=.34 P=.56 | 8 (3.0%) | 14 (2.4%) | 11 (2.6%) | 3 (1.9%) | X2 = 0.48; df(3); P=.92 P=.51 |
Same-sex couple N(%) | 32 (2.2%) | 1460 | 29 (2.8%) | 0 (0%) | 2 (2.5%) | 0 (0%) | 1 (1.3%) | X2 = 7.5; df(4); P= .11 P=.28 | 5 (1.9%) | 2 (2.4%) | 3 (1.0%) | 22 (2.8%) | X2 = 3.4; df(3); P=.34 P=.11 | 4 (1.5%) | 20 (3.4%) | 5 (1.2%) | 3 (1.9%) | X2 = 6.6; df(3); P=.09 P=.09 |
Unexplained N(%) | 550 (37.7%) | 1460 | 395 (37.5%) | 29 (28.4%) | 30 (38.0%) | 63 (43.2%) | 33 (42.8%) | X2 = 6.2; df(4); P=.19 P=.38 | 91 (34.5%) | 24 (28.9%) | 99 (33.0%) | 327 (41.4%) | X2 = 11.4; df(3); P=.01 P=.12 | 71 (26.2%) | 224 (38.0%) | 182 (42.8%) | 66 (42.6%) | X2 = 21.6; df(3); P<.001 P=.002 |
Barriers to Accessing Fertility Care

Barrier | Overall | White | Black | Hispanic | Asian | Multiple/Other | Unadjusted χ2 P Value Adjusted P value ∗ Adjusted models include the following covariate set: age (<35, 35–37, 38–40, 41–42, >42); parity (parous vs. nulliparous); race/ethnicity (White, Black, Latinx, Asian, multiple/other); household income (<$100 $100–200K, $200–400K, >$400K); religion (Catholic, Protestant, Jewish, Nonreligious or Spiritual, other Christian, Hindu, other); education (less than bachelor’s, bachelor’s, master’s, terminal professional degrees); insurance coverage for fertility treatment (none, <50%, 50%–75% coverage; >75% coverage); and an indicator of whether the respondent is currently seeking/undergoing fertility treatment or if they have completed fertility treatment in the past. | No coverage | <50% coverage | 50%–74% coverage | 75%–100% coverage | Unadjusted X2 P Value Adjusted P value ∗ Adjusted models include the following covariate set: age (<35, 35–37, 38–40, 41–42, >42); parity (parous vs. nulliparous); race/ethnicity (White, Black, Latinx, Asian, multiple/other); household income (<$100 $100–200K, $200–400K, >$400K); religion (Catholic, Protestant, Jewish, Nonreligious or Spiritual, other Christian, Hindu, other); education (less than bachelor’s, bachelor’s, master’s, terminal professional degrees); insurance coverage for fertility treatment (none, <50%, 50%–75% coverage; >75% coverage); and an indicator of whether the respondent is currently seeking/undergoing fertility treatment or if they have completed fertility treatment in the past. | <$100,000 | $100,001–$200,000 | $200,001–$400,000 | >$400,000 | Unadjusted X2 P value Adjusted P value ∗ Adjusted models include the following covariate set: age (<35, 35–37, 38–40, 41–42, >42); parity (parous vs. nulliparous); race/ethnicity (White, Black, Latinx, Asian, multiple/other); household income (<$100 $100–200K, $200–400K, >$400K); religion (Catholic, Protestant, Jewish, Nonreligious or Spiritual, other Christian, Hindu, other); education (less than bachelor’s, bachelor’s, master’s, terminal professional degrees); insurance coverage for fertility treatment (none, <50%, 50%–75% coverage; >75% coverage); and an indicator of whether the respondent is currently seeking/undergoing fertility treatment or if they have completed fertility treatment in the past. |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. (%) | No. (%) | No. (%) | No. (%) | ||||||||||||||
Race/ ethnicity | 30 (2.1) | 0 (0) | 15 (14.7) | 4 (5.1) | 7 (4.8) | 4 (5.1) | X2 = 115.8; P<.001 P=.01 | 4 (1.5) | 6 (7.2) | 12 (4.0) | 8 (1.0) | X2 = 21.0; P<.001 P=.007 | 4 (1.5) | 6 (7.2) | 12 (4.0) | 8 (1.0) | P<.001 P=.39 |
Religion | 36 (2.5) | 27 (2.6) | 1 (1.0) | 1 (1.3) | 6 (4.1) | 1 (1.3) | X2 = 3.6; P=.47 P=.66 | 5 (1.9) | 4 (4.8) | 8 (2.7) | 19 (2.4) | X2 = 2.3; P=.52 P=.84 | 5 (1.9) | 4 (4.8) | 8 (2.7) | 19 (2.4) | P=.52 P=.02 |
Age | 153 (10.5) | 79 (7.5) | 26 (25.5) | 13 (16.5) | 24 (16.4) | 11 (13.9) | X2 = 44.0; P<.001 P=.02 | 36 (13.6) | 10 (12.1) | 34 (11.3) | 73 (9.3) | X2 = 4.4; P=.22 P=.44 | 36 (13.6) | 10 (12.1) | 34 (11.3) | 73 (9.3) | P=.22 P=.44 |
Profession | 139 (9.5) | 93 (8.8) | 5 (4.9) | 7 (8.9) | 22 (15.1) | 12 (15.2) | X2 = 11.3;P=.02 P=.16 | 21 (8.0) | 12 (14.5) | 30 (10.0) | 74 (9.4) | X2 = 3.2; P=.36 P=.40 | 21 (8.0) | 12 (14.5) | 30 (10.0) | 74 (9.4) | P=.36 P=.30 |
Income level | 184 (12.6) | 115 (10.9) | 27 (26.5) | 16 (20.3) | 15 (10.3) | 11 (13.9) | X2 = 25.6; P<.001 P=.54 | 64 (24.2) | 20 (24.1) | 41 (13.7) | 58 (7.4) | X2 = 61.9; P<.001 P<.001 | 64 (24.2) | 20 (24.1) | 41 (13.7) | 58 (7.4) | P<.001 P<.001 |
Insurance status | 243 (16.6) | 161 (15.3) | 19 (18.6) | 17 (21.5) | 33 (22.6) | 13 (16.5) | X2 = 6.8; P=.15 P=.12 | 115 (43.6) | 24 (28.9) | 46 (15.3) | 56 (7.1) | X2 = 197.7; P<.001 P<.001 | 115 (43.6) | 24 (28.9) | 46 (15.3) | 56 (7.1) | P<.001 P<.001 |
Sexuality | 27 (1.9) | 21 (2.0) | 2 (2.0) | 1 (1.3) | 1 (.7) | 2 (2.5) | X2 = 1.6; P=.82 P=.54 | 6 (2.3) | 0 (0) | 4 (1.3) | 16 (2.0) | X2 = 2.4; P=.49 P=.91 | 6 (2.3) | 0 (0) | 4 (1.3) | 16 (2.0) | P=.49 P=.18 |
Citizen status | 5 (0.3) | 2 (0.2) | 0 (0) | 0 (0) | 3 (2.1) | 0 (0 ) | X 2 = 14.2; P=.007 P= N.E. | 1 (0.4) | 1 (1.2) | 0 (0) | 3 (0.4) | X2 =2.8; P=.42 P= N.E. | 1 (0.4) | 1 (1.2) | 0 (0) | 3 (0.4) | P=.42 P= N.E. |
Gender identity | 5 (0.3) | 4 (0.4) | 1 (1.0) | 0 (0) | 0 (0) | 0 (0 ) | X2 = 2.3; P=N.E. | 2 (0.8) | 0 (0) | 2 (0.7) | 1 (0.1) | X2 = 3.6; P=.31 P= N.E. | 2 (0.8) | 0 (0) | 2 (0.7) | 1 (0.1) | P=.31 P= N.E. |
Weight | 61 (4.2) | 37 (3.5) | 8 (7.8) | 7 (8.9) | 5 (3.4) | 4 (5.1) | X2 = 9.3; P=.05 P=.69 | 12 (4.6) | 4 (4.8) | 16 (5.3) | 27 (3.4) | X2 = 2.3; P=.51 P=.62 | 12 (4.6) | 4 (4.8) | 16 (5.3) | 27 (3.4) | P=.51 P=.90 |
Relationship status | 58 (4.0) | 30 (2.9) | 14 (13.7) | 3 (3.8) | 5 (3.4) | 6 (7.6) | X2 = 31.8; P<.001 P=.79 | 19 (7.2) | 6 (7.2) | 13 (4.3) | 18 (2.3) | X2 = 15.8; P=.001 P=.04 | 19 (7.2) | 6 (7.2) | 13 (4.3) | 18 (2.3) | P=.001 P<.001 |
None | 774 (53.0) | 594 (56.4) | 42 (41.2) | 40 (50.6) | 57 (39.0) | 41 (51.9) | X2 = 22.1; P<.001 P=.08 | 93 (35.2) | 37 (44.6) | 155 (51.7) | 476 (60.3) | X2 = 53.1; P<.001 P<.001 | 93 (35.2) | 37 (44.6) | 155 (51.7) | 476 (60.3) | P<.001 P<.001 |
Other | 31 (2.1) | 23 (2.2) | 1 (1.0) | 1 (1.3) | 3 (2.1) | 3 (3.8) | X2 = 2.0; P=.73 P=.57 | 6 (2.3) | 4 (4.8) | 3 (1.0) | 17 (2.2) | X2 = 4.8; P=.19 P=.19 | 6 (2.3) | 4 (4.8) | 3 (1.0) | 17 (2.2) | P=.19 P=.84 |
Discussion
United States Census Bureau. American Community Survey 2018. Available at: https://www.census.gov/acs/www/data/data-tables-and-tools/data-profiles/2018/. Accessed February 16, 2021.
United States Census Bureau. American Community Survey 2018. Available at: https://www.census.gov/acs/www/data/data-tables-and-tools/data-profiles/2018/. Accessed February 16, 2021.
Acknowledgments
Supplementary data
- Supplemental Figure 1
Survey respondents on the basis of residential zip code displayed on map of Northeast Illinois (greater Chicago area), Northwest Indiana, and Southeast Wisconsin.
- Supplemental Figure 2
Survey instrument used for the study
References
- Infertility and impaired fecundity in the United States, 1982-2010: data from the National Survey of Family Growth.Natl Health Stat Report. 2013; 67: 1-18
- 30 years of data: impact of the United States in vitro fertilization data registry on advancing fertility care.Fertil Steril. 2019; 111: 477-488
- Trends in embryo-transfer practice and in outcomes of the use of assisted reproductive technology in the United States.N Engl J Med. 2004; 350: 1639-1645
- The economic impact of assisted reproductive technology: a review of selected developed countries.Fertil Steril. 2009; 91: 2281-2294
- Cultural factors contributing to health care disparities among patients with infertility in Midwestern United States.Fertil Steril. 2011; 95: 1943-1949
- Utilization of infertility services: how much does money matter?.Health Serv Res. 2007; 42: 971-989
- Ethics Committee of the American Society for Reproductive Medicine. Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion.Fertil Steril. 2015; 104: 1104-1110
- Household Income: 2018 American Community Survey Briefs.US Census Bureau, 2019
- Disparities in access to infertility services in a state with mandated insurance coverage.Fertil Steril. 2005; 84: 221-223
- Disparities in accessing infertility care in the United States: results from the National Health and Nutrition Examination Survey, 2013-16.Fertil Steril. 2019; 112: 562-568
- Insurance coverage and outcomes of in vitro fertilization.N Engl J Med. 2002; 347: 661-666
- To pay or not to pay.Fertil Steril. 2003; 80: 27-29
- Surfing the waves of change in reproductive medicine: past, present and future. A presentation of the 2014 ASRM Strategic Plan.Fertil Steril. 2015; 103: 35-38
Adashi E, Bell A, Farquhar C, Allen B, de Ziegler D, Fujimoto V et al. White paper: Access to Care Summit 2015. Available at: https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/news-and-research/press-releases-and-bulletins/pdf/atcwhitepaper.pdf. Accessed February 16, 2021.
- Toward a better understanding of racial disparities in utilization and outcomes of IVF treatment in the USA.in: Sharara F.I. Ethnic differences in fertility and assisted reproduction. Springer New York, New York, NY2013: 239-244
- Proceedings from the conference on Reproductive Problems in Women of Color.Fertil Steril. 2010; 94: 7-10
- Socioeconomic and racial disparities among infertility patients seeking care.Fertil Steril. 2006; 85: 876-881
United States Census Bureau. American Community Survey 2018. Available at: https://www.census.gov/acs/www/data/data-tables-and-tools/data-profiles/2018/. Accessed February 16, 2021.
- Structural racism and health inequities: old issues, new directions.Du Bois Rev. 2011; 8: 115-132
- Structural racism and health inequities in the USA: evidence and interventions.Lancet. 2017; 389: 1453-1463
- Reproductive desires and disappointments.Med Anthropol. 2018; 37: 91-100
- Understanding the perceptions of and emotional barriers to infertility treatment: a survey in four European countries.Hum Reprod. 2012; 27: 1073-1079
- Progress toward the healthy people 2010 goals and objectives.Annu Rev Public Health. 2010; 31: 271-281
- High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.Am J Obstet Gynecol. 2003; 188: 100-107
- Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.Obstet Gynecol. 1997; 90: 967-973
- The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters.Am J Obstet Gynecol. 2008; 198: 168.e19
- Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.J Reprod Med. 1996; 41: 483-490
- Impact of closure of a sexually transmitted disease clinic on public health surveillance of sexually transmitted diseases--Washington, D.C., 1995.JAMA. 1999; 281: 127-128
- Racial and ethnic disparities in assisted reproductive technology outcomes in the United States.Fertil Steril. 2010; 93: 382-390
Article info
Publication history
Footnotes
All authors have nothing to disclose.
Identification
Copyright
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy